Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...   Read More

What you need to know about the federal government’s health spending projections

By Holly Campbell  |    July 14, 2016
New National Health Expenditure (NHE) projections released today by the Centers for Medicare & Medicaid Services reaffirm how our nation’s competitive marketplace for medicines controls costs...   Read More

New report: Eliminating hepatitis C today could reduce future U.S. health care spending by $115 billion over the next decade

By Holly Campbell  |    September 24, 2015
Costs and Consequences is a blog series examining the health care burden of not treating diseases. Too often, the rhetoric focuses solely on the cost of medicines and disregards the adverse...   Read More

Yet Another Misleading Report on Medicine Prices

By Robert Zirkelbach  |    May 13, 2015
Today Express Scripts released yet another misleading report to promote a false narrative about medicine spending in the United States.  For more than 50 years, spending on medicines has...   Read More

What You Need to Know about the New Kaiser Poll

By Robert Zirkelbach  |    April 22, 2015
Spending on retail prescription medicines has consistently accounted for just 10 percent of health care spending, even though biopharmaceutical companies have brought more than 500 medicines to...   Read More

Medicare Monday: Gaining Part D Coverage Reduces Hospitalizations and Overall Spending in Medicare

By Allyson Funk  |    March 30, 2015
As you learned in last week’s video, Medicare Part D helps seniors adhere to their medicines by providing access to prescription drug coverage. This helps beneficiaries live healthier lives by...   Read More

The Five Essential Truths about Prescription Drug Spending

By Robert Zirkelbach  |    March 10, 2015
This blog post has been updated. Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail...   Read More

New Report: Forecasts for Specialty Medicines Have Been Overstated

By Jennifer Bryant  |    February 9, 2015
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...   Read More

Wanted: A Balanced Discussion on Health Care Costs

By Robert Zirkelbach  |    January 15, 2015
1-26-15 UPDATE: In response to the op-ed referenced below, The New York Times posted a Letter To The Editor from PhRMA President & CEO John Castellani.   Read More

Prescription Drug Lifecycle Helps Health Care Spending Hit Record Low

By Holly Campbell  |    December 5, 2014
Following several years of modest growth, a new study published in Health Affairs reports a record low health care spending increase of 3.6 percent in 2013. The last time the annual growth rate was...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates